Jan. 20, 2023
Ophthalmology Update is a publication for physicians. It highlights trends in ophthalmology-related procedures and research at Mayo Clinic.
To contact the Department of Ophthalmology at Mayo Clinic for a referral or physician consultation, please call 507-284-2744.
2022 Issues
Vol. 12, No. 3, 2022 (PDF)
- New Study Assesses the Risk of Stroke Before and After Central Retinal Artery Occlusion
- Drusen Phenotypes Associated With Advanced Age-Related Macular Degeneration
- Coming Soon: Ophthalmology Podcast
Vol. 12, No. 2, 2022 (PDF)
- Children With Type 2 Diabetes Develop Vision-Threatening Retinopathy Sooner and at a Higher Rate Than Children With Type 1 Diabetes
- Reexamining the Relationship Among Metabolic Syndrome, CCT and Ocular Hypertension
Vol. 12, No. 1, 2022 (PDF)
- Many Ophthalmic irAEs Can Be Treated Without Discontinuation of Life-Prolonging Immunotherapy
- Mobile Platform Obtains Quantitative Measurements of Exophthalmos With Variability Similar to Hertel Exophthalmometry
- Optic Effect on Peripheral Retinal Illumination Holds Implications for Negative Dysphotopsia
2021 Issues
Vol. 11, No. 3, 2021 (PDF)
- Patients May Receive Cataract Surgery if Diabetic Macular Edema is Managed Pre- and Post-Surgery
- IPL-MGX Improves Dry Eye Symptoms More Than MGX Alone in Treating Ocular Rosacea With Dry Eye
- Netarsudil Significantly Reduces Intraocular Pressure in Patients With Primary Open-Angle Glaucoma
Vol. 11, No. 2, 2021 (PDF)
- Disease expression and familial transmission in Fuchs' endothelial dystrophy
- Study supports the use of plaque imaging in the evaluation of patients with acute retinal artery occlusion
- Genomic sequencing shows promise in elucidating genetic causes of strabismus
Vol. 11, No. 1, 2021 (PDF)
- Studies Support Scheimpflug Tomography's Efficacy in Predicting the Prognosis of FECD
- Standardized Prescribing Guidelines Reduce Frequency and Quantity of Opioids Prescribed
- Fibrin Hydrogels Provide Safe, Degradable Scaffolds for Subretinal Implantation